Dr. Nikil R Revuri is a Clifton, New Jersey based male rheumatologist who is specialized in Rheumatology. Active license number of Dr. Nikil R Revuri for Rheumatology is 25MA12148200 in New Jersey. Dr. Nikil R Revuri treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Dr. Nikil R Revuri speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
MD
Gender:
Male
Practice Address:
2 Brighton Rd, Clifton, New Jersey, 07012-1663
Phone:
973-437-2630
Fax:
862-660-6695
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1447710645
NPI Enumeration Date:
22 Mar, 2019
NPI Last Update On:
18 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Nikil R Revuri are as mentioned below.
License Number
Specialization
State
Status
25MA12148200
Rheumatologist
New Jersey
Primary
280414
Internal Medicine
Massachusetts
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1 Diamond Hill Rd, Berkeley Heights, New Jersey
Zip:
07922-2104
Phone Number:
908-273-4300
Fax Number:
--
Patients can reach Dr. Nikil R Revuri at 2 Brighton Rd, Clifton, New Jersey or can call to book an appointment on 973-437-2630. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.